Published in Proc Natl Acad Sci U S A on August 01, 1990
Rates of spontaneous mutation. Genetics (1998) 14.89
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature (2003) 10.76
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02
Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A (1993) 5.42
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes. J Virol (1991) 5.03
Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol (1994) 4.35
Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci U S A (1993) 4.04
Viral mutation rates. J Virol (2010) 3.87
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Recombinant origin of the retrovirus XMRV. Science (2011) 3.54
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc Natl Acad Sci U S A (2004) 2.99
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J Virol (2007) 2.95
Optimization of scarless human stem cell genome editing. Nucleic Acids Res (2013) 2.78
Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol (1997) 2.72
In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol (1997) 2.71
Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses. J Virol (1993) 2.55
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med (2010) 2.43
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res (2004) 2.28
Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J Virol (1991) 1.97
Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc Natl Acad Sci U S A (1992) 1.93
Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci U S A (2004) 1.91
The rate and character of spontaneous mutation in an RNA virus. Genetics (2002) 1.79
Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J Virol (1994) 1.76
Hypermutagenic PCR involving all four transitions and a sizeable proportion of transversions. Nucleic Acids Res (1996) 1.67
Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol (2010) 1.65
Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62
High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci U S A (1992) 1.60
A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J (1994) 1.58
Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference. J Virol (1997) 1.57
Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G. Curr Biol (2008) 1.51
Replication infidelity during a single cycle of Ty1 retrotransposition. Proc Natl Acad Sci U S A (1996) 1.45
Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection. J Virol (2003) 1.44
Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J Virol (1995) 1.43
Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J Virol (1999) 1.42
Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate. J Virol (1998) 1.40
Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J Mol Biol (2013) 1.39
Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol (2000) 1.38
Exploring the functional robustness of an enzyme by in vitro evolution. EMBO J (1996) 1.38
The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res (1994) 1.36
Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol (1998) 1.34
E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J Virol (1995) 1.32
Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion. J Virol (1992) 1.32
Replication of the retroviral terminal repeat sequence during in vivo reverse transcription. J Virol (1993) 1.29
HIV-1 reverse transcription. Cold Spring Harb Perspect Med (2012) 1.29
APOBECs and virus restriction. Virology (2015) 1.27
Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucleic Acids Res (1997) 1.27
3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. J Virol (2000) 1.26
Direct determination of the point mutation rate of a murine retrovirus. J Virol (1992) 1.25
Origin and evolution of SINEs in eukaryotic genomes. Heredity (Edinb) (2011) 1.23
Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol (1999) 1.23
Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J Virol (2010) 1.22
High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J Virol (1993) 1.21
Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses (2009) 1.19
In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J Virol (2000) 1.18
Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc Natl Acad Sci U S A (1992) 1.18
Appreciating HIV type 1 diversity: subtype differences in Env. AIDS Res Hum Retroviruses (2009) 1.17
Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol (2002) 1.16
High rate of mismatch extension during reverse transcription in a single round of retrovirus replication. Proc Natl Acad Sci U S A (1994) 1.16
The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate. J Virol (1997) 1.16
Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol (1996) 1.14
Mispair extension fidelity of human immunodeficiency virus type 1 reverse transcriptases with amino acid substitutions affecting Tyr115. Nucleic Acids Res (1997) 1.14
Functional and biological properties of an avian variant long terminal repeat containing multiple A to G conversions in the U3 sequence. J Virol (1994) 1.14
Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis. Nucleic Acids Res (1994) 1.13
High rates of frameshift mutations within homo-oligomeric runs during a single cycle of retroviral replication. J Virol (1994) 1.12
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol (1998) 1.12
High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08
Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol (2004) 1.05
Lethal mutagenesis: targeting the mutator phenotype in cancer. Semin Cancer Biol (2010) 1.05
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. J Virol (1999) 1.04
Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus. Nucleic Acids Res (1995) 1.03
Construction and characterization of a replication-competent retroviral shuttle vector plasmid. J Virol (2002) 1.03
Mechanisms and factors that influence high frequency retroviral recombination. Viruses (2011) 1.02
Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Proc Natl Acad Sci U S A (2002) 1.01
Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo. J Virol (2002) 1.01
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif. Front Microbiol (2014) 1.00
Frequency of spontaneous mutations in an avian hepadnavirus infection. J Virol (2001) 0.98
Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity. J Virol (2000) 0.97
Homologous recombination promoted by reverse transcriptase during copying of two distinct RNA templates. Proc Natl Acad Sci U S A (1995) 0.97
Oligo(A) sequences of human respiratory syncytial virus G protein gene: assessment of their genetic stability in frameshift mutants. J Virol (1994) 0.96
In vivo evolution of c-rel oncogenic potential. J Virol (1994) 0.92
Accuracy estimation of foamy virus genome copying. Retrovirology (2009) 0.92
Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res (2008) 0.88
Increased G-->A transition frequencies displayed by primer grip mutants of human immunodeficiency virus type 1 reverse transcriptase. J Virol (2004) 0.87
Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNA. J Virol (1996) 0.87
Few mutations in the 5' leader region mediate fitness recovery of debilitated human immunodeficiency type 1 viruses. J Virol (2005) 0.86
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector. J Virol (2001) 0.86
Mechanisms of viral mutation. Cell Mol Life Sci (2016) 0.85
Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells. Retrovirology (2005) 0.85
APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1. Med Microbiol Immunol (2011) 0.83
Human immunodeficiency virus type 1 reverse transcriptase tG:T mispair formation on RNA and DNA templates with mismatched primers: a kinetic and thermodynamic study. EMBO J (1995) 0.83
Size variation within the second hypervariable region of the surface envelope gene of the bovine lentivirus BIV in experimentally and naturally infected cattle. J Virol (1997) 0.82
Fate of direct and inverted repeats in the RNA hypermutagenesis reaction. Nucleic Acids Res (1996) 0.82
Copackaging of different-sized retroviral genomic RNAs: little effect on retroviral replication or recombination. J Virol (1994) 0.82
Genetic elements of plant viruses as tools for genetic engineering. Microbiol Rev (1995) 0.80
Fidelity of reverse transcriptase of the simian immunodeficiency virus from African green monkey. Nucleic Acids Res (1991) 0.80
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance. Mol Gen Genet (1979) 19.37
Frameshift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday. Cold Spring Harb Symp Quant Biol (1966) 14.57
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
The accuracy of reverse transcriptase from HIV-1. Science (1988) 8.24
Fidelity of HIV-1 reverse transcriptase. Science (1988) 8.08
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66
The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation. J Biol Chem (1986) 4.25
Genetic control of mutation rates in bacteriophageT4. Nature (1969) 4.06
Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers. Nucleic Acids Res (1989) 3.99
Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J Biol Chem (1989) 3.80
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro. Mol Cell Biol (1989) 3.00
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88
Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependent. EMBO J (1990) 2.64
The control of cellular morphology in embryonic cells infected with rous sarcoma virus in vitro. Virology (1960) 2.39
Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues. Proc Natl Acad Sci U S A (1985) 2.25
High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1987) 2.12
Thermodynamic origins of specificity in the lac repressor-operator interaction. Adaptability in the recognition of mutant operator sites. J Mol Biol (1985) 2.00
Instability of large direct repeats in retrovirus vectors. J Virol (1987) 1.78
Determination of the mutation rate of a retrovirus. J Virol (1988) 1.75
Variation in avian retrovirus genomes. Ann N Y Acad Sci (1980) 1.75
Mixed infection with two types of Rous sarcoma virus. Virology (1961) 1.39
Radioimmunological comparison of the DNA polymerases of avian retroviruses. J Virol (1980) 1.16
A competition immunoassay for characterizing the reverse transcriptase of mammalian RNA tumor viruses. Virology (1978) 1.10
RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Retroviral recombination and reverse transcription. Science (1990) 6.27
RNA-directed DNA synthesis and RNA tumor viruses. Adv Virus Res (1972) 6.11
Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature (1980) 5.95
Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene. Proc Natl Acad Sci U S A (1982) 5.56
Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol Cell Biol (1983) 4.96
Structure, variation and synthesis of retrovirus long terminal repeat. Cell (1981) 4.90
The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature (1984) 4.89
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc Natl Acad Sci U S A (1984) 4.81
Studies on carcinogenesis by avian sarcoma viruses. VI. Differential multiplication of uninfected and of converted cells in response to insulin. J Cell Physiol (1967) 4.55
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 4.29
Mechanism of cell transformation by RNA tumor viruses. Annu Rev Microbiol (1971) 4.24
Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J Virol (1984) 4.17
Carcinogenesis by RNA sarcoma viruses. XII. A quantitative study of infection of rat cells in vitro by avian sarcoma viruses. Virology (1970) 3.90
Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell (1981) 3.80
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Origin of retroviruses from cellular moveable genetic elements. Cell (1980) 3.67
Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity. J Virol (1973) 3.62
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus. J Virol (1980) 3.53
Circles with two tandem LTRs are precursors to integrated retrovirus DNA. Cell (1984) 3.45
Stimulation by serum of multiplication of stationary chicken cells. J Cell Physiol (1971) 3.41
Cell cycle-dependent activation of rous sarcoma virus-infected stationary chicken cells: avian leukosis virus group-specific antigens and ribonucleic acid. J Virol (1972) 3.35
A DNA-depenent DNA polymerase and a DNA endonuclease in virions of Rous sarcoma virus. Nature (1970) 3.31
Formation and structure of infectious DNA of spleen necrosis virus. J Virol (1977) 3.29
Replication of reticuloendotheliosis viruses in cell culture: acute infection. J Virol (1974) 3.17
High-efficiency ligation and recombination of DNA fragments by vertebrate cells. Science (1983) 2.99
Comparison of Rous sarcoma virus-specific deoxyribonucleic acid polymerases in virions of Rous sarcoma virus and in Rous sarcoma virus-infected chicken cells. J Virol (1971) 2.97
Function of the retrovirus long terminal repeat. Cell (1982) 2.89
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J Virol (1989) 2.86
Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J Virol (1974) 2.86
Infectious rous sarcoma virus and reticuloendotheliosis virus DNAs. J Virol (1974) 2.77
Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J Virol (1977) 2.71
Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science (1993) 2.64
Reticuloendotheliosis virus nucleic acid sequences in cellular DNA. J Virol (1974) 2.55
Characterization of reticuloendotheliosis virus strain T DNA and isolation of a novel variant of reticuloendotheliosis virus strain T by molecular cloning. J Virol (1981) 2.49
Lack of serological relationship among DNA polymerases of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken cells. J Virol (1973) 2.46
Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector. Nature (1982) 2.38
The partial purification from calf serum of a fraction with multiplication-stimulating activity for chicken fibroblasts in cell culture and with non-suppressible insulin-like activity. J Cell Physiol (1972) 2.37
Infectious and noninfectious recombinant clones of the provirus of SNV differ in cellular DNA and are apparently the same in viral DNA. Cell (1980) 2.35
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol (1979) 2.33
The DNA provirus hypothesis. Science (1976) 2.31
Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection. J Virol (1982) 2.26
Studies on carcinogenesis by avian sarcoma viruses. 8. Glycolysis and cell multiplication. Int J Cancer (1968) 2.25
Spontaneous changes in nucleotide sequence in proviruses of spleen necrosis virus, an avian retrovirus. Proc Natl Acad Sci U S A (1982) 2.16
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13
Cell killing by avian leukosis viruses. J Virol (1981) 2.10
v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J Virol (1988) 2.08
Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol Cell Biol (1986) 2.08
5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J Virol (1992) 2.03
Light inactivation of focus formation by chicken embryo fibroblasts infected with avian sarcoma virus in the presence of 5-bromodeoxyuridine. Nature (1970) 2.02
Lack of infectivity of the endogenous avian leukosis virus-related genes in the DNA of uninfected chicken cells. J Virol (1976) 1.99
Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell (1986) 1.96
A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts. J Cell Physiol (1973) 1.93
The protovirus hypothesis: speculations on the significance of RNA-directed DNA synthesis for normal development and for carcinogenesis. J Natl Cancer Inst (1971) 1.93
Hybridization of Rous sarcoma virus deoxyribonucleic acid polymerase product and ribonucleic acids from chicken and rat cells infected with Rous sarcoma virus. J Virol (1972) 1.91
Multiplication-stimulating activity for chicken embryo fibroblasts from rat liver cell conditioned medium: a family of small polypeptides. J Cell Physiol (1973) 1.87
Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol Cell Biol (1989) 1.87
Sites of integration of reticuloendotheliosis virus DNA in chicken DNA. Proc Natl Acad Sci U S A (1978) 1.86
Insertion of several different DNAs in reticuloendotheliosis virus strain T suppresses transformation by reducing the amount of subgenomic mRNA. J Virol (1986) 1.83
The mechanism of carcinogenesis by avian sarcoma viruses. 1. Cell multiplication and differentiation. J Natl Cancer Inst (1965) 1.82
The cellular and molecular biology of RNA tumor viruses, especially avian leukosis-sarcoma viruses, and their relatives. Adv Cancer Res (1974) 1.81
Instability of large direct repeats in retrovirus vectors. J Virol (1987) 1.78
Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J Virol (1994) 1.76
Enzymes and nucleotides in virions of Rous sarcoma virus. J Virol (1971) 1.74
Reverse transcriptases. Retrons in bacteria. Nature (1989) 1.74
High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters. J Virol (1984) 1.73
No apparent nucleotide sequence specificity in cellular DNA juxtaposed to retrovirus proviruses. Proc Natl Acad Sci U S A (1980) 1.72
DNA of noninfectious and infectious integrated spleen necrosis virus (SNV) is colinear with unintegrated SNV DNA and not grossly abnormal. Cell (1979) 1.71
DNA ligase and exonuclease activities in virions of rous sarcoma virus. Nat New Biol (1971) 1.71
Retrovirus recombination depends on the length of sequence identity and is not error prone. J Virol (1994) 1.70
Spontaneous variation and synthesis in the U3 region of the long terminal repeat of an avian retrovirus. J Virol (1982) 1.69
Substitution of 5' helper virus sequences into non-rel portion of reticuloendotheliosis virus strain T suppresses transformation of chicken spleen cells. Cell (1982) 1.69
Replication of reticuloendotheliosis viruses in cell culture: chronic infection. J Gen Virol (1975) 1.68
Specific serological relationships among partially purified DNA polymerases of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and avian cells. J Virol (1974) 1.61
One retroviral RNA is sufficient for synthesis of viral DNA. J Virol (1994) 1.60
Infectious DNA of spleen necrosis virus is integrated at a single site in the DNA of chronically infected chicken fibroblasts. Proc Natl Acad Sci U S A (1977) 1.58
Expression of complete chicken thymidine kinase gene inserted in a retrovirus vector. Mol Cell Biol (1984) 1.58
A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J (1994) 1.58
Sites of integration of infectious DNA of avian reticuloendotheliosis viruses in different avian cellular DNAs. Cell (1978) 1.57
The RNA tumor viruses--background and foreground. Proc Natl Acad Sci U S A (1972) 1.56
Ribonuclease-sensitive deoxyribonucleic acid polymerase activity in uninfected rat cells and rat cells infected with Rous sarcoma virus. J Virol (1971) 1.54
On the origin of RNA tumor viruses. Annu Rev Genet (1974) 1.53
Recombination of transfected DNAs in vertebrate cells in culture. Proc Natl Acad Sci U S A (1984) 1.50
Retroviral vector system for the study of cDNA gene formation. Mol Cell Biol (1988) 1.50
Endogenous RNA-directed DNA polymerase activity in uninfected chicken embryos. Proc Natl Acad Sci U S A (1972) 1.49
Control by factors in serum of multiplication of uninfected cells and cells infected and converted by avian sarcoma viruses. Wistar Inst Symp Monogr (1967) 1.46
Effect of gamma radiation on retroviral recombination. J Virol (1992) 1.43
Expression from an internal AUG codon of herpes simplex thymidine kinase gene inserted in a retrovirus vector. Mol Cell Biol (1984) 1.42
The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters. Oncogene (1988) 1.41
Studies on carcinogenesis by avian sarcoma viruses. 3. The differential effect of serum and polyanions on multiplication of uninfected and converted cells. J Natl Cancer Inst (1966) 1.41
Structure and expression of c-rel, the cellular homolog to the oncogene of reticuloendotheliosis virus strain T. J Virol (1983) 1.40
The efficiency of RNA 3'-end formation is determined by the distance between the cap site and the poly(A) site in spleen necrosis virus. Genes Dev (1990) 1.37